Characterization of Alzheimer Disease Biomarker Discrepancies Using P-tau and Positron Emission Tomography

This study characterizes individuals in the Alzheimer ’s Disease Neuroimaging Initiative (ADNI) data set with tau abnormality indicated by cerebrospinal fluid assay or positron emission tomography.
Source: JAMA Neurology - Category: Neurology Source Type: research